1
Total deals
$245.0M
Total value
$245.0M
Avg deal
$245.0M
Largest
| # | Acquired | Date | Type | Status | Price | |
|---|---|---|---|---|---|---|
| 1 |
Focus-X Therapeutics
Focus-X Therapeutics is a preclinical-stage biotechnology company focused on the…
|
2022-11-28 | Acquisition | Complete | $245.0M | Deal → |